Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
2(50.0%)
N/A
1(25.0%)
Phase 3
1(25.0%)
4Total
Phase 2(2)
N/A(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06786403Phase 3Not Yet Recruiting

The Effects of Bromelain Supplement in Patients with Diabetic Foot Ulcers

Role: lead

NCT03147339Not ApplicableCompleted

The Effects of Restricted Dietary of AGEs on the Glycemic Control, Oxidative Stress and Inflammation

Role: lead

NCT02535195Phase 2Completed

Effect of Ginger Supplement on Non-alcoholic Fatty Liver

Role: lead

NCT02030977Phase 2Completed

The Effects of Resveratrol Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis

Role: lead

All 4 trials loaded